top of page
Executive Spotlights

Lilly to Acquire Sigilon for an Aggregate of Approximately $309M

Indianapolis and Cambridge, MA, June 29, 2023 (PRNewswire) -- Lilly and Sigilon Therapeutics announced that they have reached a definitive agreement for Lilly to acquire Sigilon. The collaboration aims to advance encapsulated cell therapies with the goal of providing long-term relief and improved care for patients living with diabetes.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page